Director of IRB Barcelona, Joan Guinovart, was among the hundred innovators and inventors gathered in the second Kinnernet gathering in Catalonia. TV3 reported on this gathering, which the organisers describe as "irreverent, disruptor event looking for innovation, creativity and new ideas." Guinovart, accompanied by IRB Barcelona's Head of Innovation, Cristina Horcajada, said that "Kinnernet allows you to meet really interesting people: its a hotbed of new ideas".
Link to TN news, minute 14: http://www.ccma.cat/tv3/alacarta/telenoticies-vespre...
Broad international and national coverage of the study on the evolution of the genetic code published in Science Advances by Lluís Ribas, ICREA professor at IRB Barcelona. Sarah Emerson, editor of Motherboard, writes an article aimed at the general public on what caused the genetic code to stop evolving 3000 million years ago.
Read the article in Motherboard (USA)
Read the Article in Daily Mail (UK):...
The Diario de Sevilla publishes an interview with Joan J. Guinovart, director of the Institute for Research in Biomedicine (IRB Barcelona). The scientist explains that scientific research needs not only more funding but also greater flexibility with respect to the regulations governing it and greater support from society. In addition, he comments on applying science to tackle the problems associated with aging, such as Alzheimer’s disease, before the public health system becomes overburden by the cost.
Read it online:...
The newspaper published in Lleida devotes an article to the recent finding made by the researchers Felipe Slebe, Joan Guinovart and Roger Gomis in breast cancer. The authors of the study have discovered that breast cancer tumours must take up fat in order to keep growing. The LIPG protein is crucial in this process and may provide a potential therapeutic target for the development of inhibitors to block its activity.
The Government of Catalonia has published a news article that summarises the competitiveness of Catalan research centres and universities in the European Research Council (ERC) Call in 2015. The scientist Angel R. Nebreda, who belongs to the Oncology Programme and already holds an ERC Advanced Grant, has now been awarded an ERC Proof of Concept to develop drugs against breast cancer.
In an extensive interview on Radio Nacional de España, Radio Exterior, Felipe Slebe explains the breakthroughs in the fight against cancer made at IRB Barcelona.
Listen to the interview here (From minute 3.50 to minute 20):
laSexta TV News devotes time to research that has revealed that the proliferation and division of breast cancer cells is dependent on the cells taking up lipids (fats) circulating in blood.
The study explains that tumour cells have high levels of LIPG protein, a membrane protein that...
La Vanguardia, and its online science section BigVang, has published a questionnaire by Eduard Batlle, ICREA researcher and group leader of the Colorectal Cancer Laboratory at IRB Barcelona. The questionnaire reveals some interesting things about Batlle, such as his passion for football, Star Wars, and Bruce Springsteen.
The medical website farmacosalud.com devotes an article to a new research by Angel R. Nebreda, ICREA researcher and group leader of the Signalling and Cell Cycle Laboratory, on the RingoA protein and its role in meiosis—a study recently published in Nature Communications. The article explains that RingoA plays a key role in the production of sperm and eggs and that it could become a target for a male contraceptive.
The magazine of "Genética Médica News” publishes an article by Berta Terré, PhD student in the Genomic Instability and Cancer Laboratory, about the discovery of Gemc1. This new gene is essential for the generation of multiciliated cells and the association these may have with ciliopathies, a type of rare disease.